Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is a leading biotechnology company focused on acquiring, developing and commercializing drug products. The company currently markets five hematology/oncology drugs, and it expects an FDA decision on another hematology drug later this year. Additionally, Spectrum’s … Continue reading →

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for oncology and inflammation diseases in … Continue reading →

Solar3D, Inc. (NASDAQ: SLTD) is a leading provider of solar power solutions focused on the design, installation and management of solar power systems for commercial, agricultural and residential customers. Through its wholly-owned subsidiaries, the company is one of the fastest … Continue reading →

Social Reality, Inc. (OTCQB: SCRI) is an internet advertising company delivering a complete set of advertising and marketing tools and services powered by real-time automation. The company’s proprietary technology connects the social and digital spheres to offer brands, agencies and … Continue reading →

Smith Micro Software, Inc. (NASDAQ: SMSI) is a provider of software designed to simplify and enhance the mobile experience. As the leader in wireless connectivity, the company’s applications ensure the best quality of experience for mobile users while simultaneously optimizing … Continue reading →

SITO Mobile Ltd. (NASDAQ: SITO) provides a mobile engagement platform that enables brands to increase awareness, loyalty and sales. Through its location-based advertising services, the company helps clients drive foot traffic into stores and improve customer loyalty. Through its mobile … Continue reading →

Signal Genetics, Inc. (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead product is its MyPRS® test, … Continue reading →

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets innovative implantable visual prosthetics that enable blind individuals to achieve greater independence. The company’s lead product is the Argus® II Retinal Prosthesis System, which is currently being studied in … Continue reading →

Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, the company has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard … Continue reading →

Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel … Continue reading →